Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vasilis Stavrinides

Showing results (11-20 of 39) with videos related to

Pageof 4
Sort By:
Nature Reviews. Urology|July 23, 2021
Cellular senescence as a possible link between prostate diseases of the ageing maleGaelle Fiard, Vasilis Stavrinides, Emma S Chambers, et al.
European Radiology|April 2, 2026
Reply to the Letter to the Editor: Variation in prostate cancer growth rates in an MRI-based active surveillance cohortHayley Smith, Vasilis Stavrinides, Francesco Giganti, et al.
European Radiology|January 16, 2026
Variation in prostate cancer growth rates in an MRI-based active surveillance cohortHayley Smith, Vasilis Stavrinides, Francesco Giganti, et al.
The Journal of Urology|December 22, 2020
Followup of Men with PI-RADS<sup>TM</sup> 4 or 5 Abnormality on Prostate Magnetic Resonance Imaging and Nonmalignant Pathological Findings on Initial Targeted Prostate Biopsy. Letter.<i>J Urol</i> 2021; <b>205:</b> 748Vasilis Stavrinides, Francesco Giganti, Clare Allen, et al.
The British Journal of Radiology|July 8, 2021
Tumour growth rates of prostate cancer during active surveillance: is there a difference between MRI-visible low and intermediate-risk disease?Francesco Giganti, Clare Allen, Vasilis Stavrinides, et al.
Cancers|August 28, 2019
The Oncogene Metadherin Interacts with the Known Splicing Proteins YTHDC1, Sam68 and T-STAR and Plays a Novel Role in Alternative mRNA SplicingHayley J Luxton, Benjamin S Simpson, Ian G Mills, et al.
The Journal of Urology|July 24, 2020
Re: Does the Visibility of Grade Group 1 Prostate Cancer on Baseline Multiparametric Magnetic Resonance Imaging Impact Clinical Outcomes?D. Deniffel, E. Salinas, M. Ientilucci, A. J. Evans, N. Fleshner, S. Ghai, R. Hamilton, A. Roberts, A. Toi, T. van der Kwast, A. Zlotta, A. Finelli, M. A. Haider and N. Perlis <i>J Urol</i> 2020; doi: 10.1097/JU.0000000000001157Vasilis Stavrinides, Francesco Giganti, Shonit Punwani, et al.
Urology|December 5, 2020
Prostate Cancer Undetected by mpMRI: Tumor Conspicuity is Reliant Upon Optimal Scan Timing and QualityJoseph M Norris, Clare Allen, Rhys Ball, et al.
Cardiovascular and Interventional Radiology|July 6, 2026
Should Interventional Radiologists Incorporate Intravascular Ultrasound (IVUS) Into Their Daily Practice? A Systematic Review and Meta-Analysis of IVUS in Peripheral Arterial Endovascular InterventionsGirija Agarwal, Rayan Kamal, Danial Saeed, et al.
BJU International|November 13, 2020
Conspicuity of cribriform prostate cancer on multiparametric magnetic resonance imaging: the jury is still outJoseph M Norris, Lina M Carmona Echeverria, Benjamin S Simpson, et al.
Pageof 4

Showing results (11-20 of 39) with videos related to

Sort By:
Pageof 4
Nature Reviews. Urology|July 23, 2021
Cellular senescence as a possible link between prostate diseases of the ageing maleGaelle Fiard, Vasilis Stavrinides, Emma S Chambers, et al.
European Radiology|April 2, 2026
Reply to the Letter to the Editor: Variation in prostate cancer growth rates in an MRI-based active surveillance cohortHayley Smith, Vasilis Stavrinides, Francesco Giganti, et al.
European Radiology|January 16, 2026
Variation in prostate cancer growth rates in an MRI-based active surveillance cohortHayley Smith, Vasilis Stavrinides, Francesco Giganti, et al.
The Journal of Urology|December 22, 2020
Followup of Men with PI-RADS<sup>TM</sup> 4 or 5 Abnormality on Prostate Magnetic Resonance Imaging and Nonmalignant Pathological Findings on Initial Targeted Prostate Biopsy. Letter.<i>J Urol</i> 2021; <b>205:</b> 748Vasilis Stavrinides, Francesco Giganti, Clare Allen, et al.
The British Journal of Radiology|July 8, 2021
Tumour growth rates of prostate cancer during active surveillance: is there a difference between MRI-visible low and intermediate-risk disease?Francesco Giganti, Clare Allen, Vasilis Stavrinides, et al.
Cancers|August 28, 2019
The Oncogene Metadherin Interacts with the Known Splicing Proteins YTHDC1, Sam68 and T-STAR and Plays a Novel Role in Alternative mRNA SplicingHayley J Luxton, Benjamin S Simpson, Ian G Mills, et al.
The Journal of Urology|July 24, 2020
Re: Does the Visibility of Grade Group 1 Prostate Cancer on Baseline Multiparametric Magnetic Resonance Imaging Impact Clinical Outcomes?D. Deniffel, E. Salinas, M. Ientilucci, A. J. Evans, N. Fleshner, S. Ghai, R. Hamilton, A. Roberts, A. Toi, T. van der Kwast, A. Zlotta, A. Finelli, M. A. Haider and N. Perlis <i>J Urol</i> 2020; doi: 10.1097/JU.0000000000001157Vasilis Stavrinides, Francesco Giganti, Shonit Punwani, et al.
Urology|December 5, 2020
Prostate Cancer Undetected by mpMRI: Tumor Conspicuity is Reliant Upon Optimal Scan Timing and QualityJoseph M Norris, Clare Allen, Rhys Ball, et al.
Cardiovascular and Interventional Radiology|July 6, 2026
Should Interventional Radiologists Incorporate Intravascular Ultrasound (IVUS) Into Their Daily Practice? A Systematic Review and Meta-Analysis of IVUS in Peripheral Arterial Endovascular InterventionsGirija Agarwal, Rayan Kamal, Danial Saeed, et al.
BJU International|November 13, 2020
Conspicuity of cribriform prostate cancer on multiparametric magnetic resonance imaging: the jury is still outJoseph M Norris, Lina M Carmona Echeverria, Benjamin S Simpson, et al.
Pageof 4